Schizophrenia Clinical Trials in Houston

View 13 new treatments for Schizophrenia in Houston, TX, and other areas near me, such as League City, Pearland and Sugar Land. Every day, Power helps hundreds of schiz patients connect with leading medical research.
View 15 trials in Houston
Filter (15)

RL-007 for Cognitive Impairment in Schizophrenia

Recognify Life Sciences Clinic, Houston + 3 more

This trial is testing a new drug, RL-007, to see if it can help people with schizophrenia think and remember better. The study will compare different doses of the drug and check for any side effects. Participants will take the drug for several weeks and complete memory and thinking tests before and after the treatment.Show More

Verified

Recruiting
Phase 2
Est. 3 - 6 Weeks
Gary Walker, PhD
Study Director

TMS for Smoking Cessation in Schizophrenia

Research Clinic, Houston + 2 more

This trial uses a magnetic pulse device to help people with schizophrenia stop smoking. It targets specific brain areas involved in both conditions. The goal is to see if this method is effective for this particular group. This method has been shown to decrease cigarette consumption in schizophrenia patients.Show More

Verified

Recruiting

No Placebo Trial

N/A
Est. 6 - 12 Weeks
Xiaoming Du, PhD
Principal Investigator

KarXT for Schizophrenia

Karuna Clinic, Houston + 4 more

This trial tests KarXT, a combination of two drugs, for people who haven't improved with their current treatment. KarXT aims to balance brain functions and reduce side effects. The study will look at improvements in health and daily life. KarXT has shown positive results in earlier tests.Show More
Recruiting
Phase 3
Est. 3 - 12 Weeks
Bruce Kinon, MD
Study Director

Cariprazine for Adolescent Schizophrenia

Allergan Clinic, The Woodlands + 1 more

The purpose of this study is to evaluate the efficacy and safety of cariprazine in the treatment of schizophrenia in the adolescent population.
Recruiting
Phase 3
Est. 3 - 6 Weeks
Paul Yeung
Study Director

Long-term Safety of Iclepertin for Schizophrenia

Boehringer Ingelheim Clinic, Richmond + 3 more

This study is open to adults with schizophrenia who took part in a previous CONNEX study (study 1346-0011, 1346-0012, or 1346-0013). The purpose of this study is to find out how well people with schizophrenia can tolerate a medicine called Iclepertin in the long term. Participants take Iclepertin as tablets once a day for 1 year. In addition, all participants take their normal medication for schizophrenia. Participants are in the study for a little more than 1 year. During this time, they visit the study site about 13 times and get about 9 phone calls from the study team. The doctors collect information on any health problems of the participants. Doctors also regularly check the participants' symptoms of schizophrenia.Show More
Recruiting

No Placebo Trial

Phase 3
Est. 5 - 8 Weeks
Unregistered Study Lead
Research Team

KarXT for Schizophrenia

Karuna Clinic, Houston + 3 more

This trial tests the safety and tolerability of KarXT, a combination of two drugs, in schizophrenia patients who haven't responded well to their current treatments. KarXT aims to improve symptoms and manage side effects better than existing medications. KarXT (xanomeline plus trospium) is an emerging treatment for schizophrenia, showing promise in managing total, positive, and negative symptoms.Show More
Recruiting

No Placebo Trial

Phase 3
Est. 3 - 12 Weeks
Bruce Kinon, MD
Study Director

Valbenazine for Schizophrenia

Neurocrine Clinic, Houston + 1 more

The primary objective for this study is to evaluate the effect of adjunctive valbenazine versus placebo on symptoms of schizophrenia in participants who have inadequate response to antipsychotic treatment.Show More
Recruiting
Phase 3
Est. 4 - 6 Weeks
Clinical Development Lead
Study Director

Digital Therapeutics for Schizophrenia

Click Clinic, Houston + 6 more

This study evaluates the efficacy of two prescription digital therapeutics (PDT) in addition to standard of care (SOC) therapy for the treatment of experiential negative symptoms of schizophrenia in late adolescents and adults.Show More
Recruiting

No Placebo Trial

Phase 3
Est. 4 - 6 Weeks
Shaheen Lakhan, MD, PhD, FAAN
Study Director

Cariprazine for Pediatric Schizophrenia

AbbVie Clinic, The Woodlands + 4 more

This trial is testing the safety and effectiveness of cariprazine in children and teens with schizophrenia, bipolar I disorder, or autism. The goal is to see if the medication is safe and beneficial for use in these young patients.Show More
Waitlist

No Placebo Trial

Phase 3
Est. 4 - 6 Weeks
ABBVIE INC.
Study Director

Emraclidine for Schizophrenia

Cerevel Clinic, Houston + 1 more

This trial aims to evaluate the safety and tolerability of a medication called emraclidine, taken by mouth, in adults with schizophrenia.
Recruiting

No Placebo Trial

Phase 2
Est. 3 - 12 Weeks
Erica Koenig, PhD
Study Director
Page 1 of 2

Frequently Asked Questions

How much do schizophrenia clinical trials pay?

Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range. Further, most trials will cover the costs of an Uber to-and-from the clinic. Factors that can affect compensation include the phase of the trial, the length of the trial, the frequency of visits, and the specific condition being studied.

Do I need to be insured to participate in a medical study?

Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on Cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.

How do schizophrenia clinical trials work?

After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll typical be sorted into one of the treatment groups, and will receive your study drug. For some trials, there is a chance you'll receive a placebo. Across schizophrenia trials in Houston, 42% of clinical trials have a placebo. Typically you'll be required to check-in with the clinic every month or two. The average trial length in this city for schizophrenia patients is 6 Months.

What does the "phase" of a clinical trial mean?

The phase of a trial reveals what stage the drug is in getting approval for a specific condition. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. Phase 2 trials are those where the drug has some data showing safety in humans, but where effectiveness has typically only been shown in animals and non-human experiments. Phase 1 trials are the trials where we don't have safety data in humans. As a general rule, phase 3 trials are more promising than phase 2, and phase 2 trials are more promising than phase 1.

Where in Houston is research being conducted for schizophrenia?

Prominent hospitals in Houston conducting schizophrenia clinical trials include Ben Taub General Hospital and The University of Texas Health Science Center. Approximately 4 trials are ongoing as of October 2023.

What promising new drugs are being tested?

In Houston, schizophrenia research includes treatments like Neuromodulation and Non-invasive Brain Stimulation. Specific drugs being studied are Cariprazine, Ocrelizumab, and Valbenazine.